Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer
Adam Sharp(Institute of Cancer Research), Johann S. de Bono(Royal Marsden NHS Foundation Trust), George Seed(Institute of Cancer Research), Antonella Petremolo(Royal Marsden NHS Foundation Trust), Pasquale Rescigno(Institute of Cancer Research), Wei Yuan(Shanghai Public Health Clinical Center), Antje Neeb(Institute of Cancer Research), Rita Pereira(Institute of Cancer Research), David Dolling(Institute of Cancer Research), Caterina Aversa(Royal Marsden NHS Foundation Trust), Joaquı́n Mateo(Royal Marsden NHS Foundation Trust), Mateus Crespo(Institute of Cancer Research), Berni Ebbs(Institute of Cancer Research), Nina Tunariu(Leicester Royal Infirmary), Changxue Lu(Johns Hopkins University), Gemma Fowler, Susana Miranda(Royal Marsden NHS Foundation Trust), Michael Kolinsky(University of Alberta), Penny Flohr(Royal Marsden NHS Foundation Trust), Stephen R. Plymate(VA Puget Sound Health Care System), Ana Ferreira(Institute of Cancer Research), Jun Luo(Johns Hopkins University), Daniel Nava Rodrigues(Institute of Cancer Research), Jon Welti(Institute of Cancer Research), Suzanne Carreira(Institute of Cancer Research), Lorna Pope(Institute of Cancer Research), Diletta Bianchini(Royal Marsden NHS Foundation Trust), Jennifer A. Fraser(Edinburgh Napier University), Alec Paschalis(Royal Marsden NHS Foundation Trust), Zai Ahmad(Institute of Cancer Research), Ruth Riisnaes(Institute of Cancer Research), Ines Figueiredo(Institute of Cancer Research), Cláudia Bertan(Institute of Cancer Research), Maryou B. Lambros(Institute of Cancer Research), Semini Sumanasuriya(Institute of Cancer Research)
Cited by 83
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k